SMRT:PA:PA-Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 522.5749

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

8.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.35 (+0.74%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.68%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

+0.21 (+0.64%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.95 (+0.39%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.70 (+0.84%)

USD 7.98B
HHH:PA HSBC ETFs Public Limited Compa..

+0.36 (+0.70%)

USD 7.03B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.09 (+0.62%)

USD 6.87B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.13 (+0.73%)

USD 6.47B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.11 (+0.57%)

USD 5.17B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.68 (+0.46%)

USD 4.78B

ETFs Containing SMRT:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 26.10% 44% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.10% 43% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 7.05% 58% F 60% D-
Dividend Return 7.05% 57% F 57% F
Total Return N/A 99% N/A 100% F
Risk Return Profile  
Volatility (Standard Deviation) 12.90% 52% F 72% C
Risk Adjusted Return 54.60% 52% F 70% C-
Market Capitalization 0.03B 15% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.